Skip to content

A clinical study to find out how Mandukparni Churna helps in reducing anxiety Generalized Anxiety Disorder

A RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFECT OF MANDUKPANRNI CHURNA IN THE MANAGEMENT OF CHITTODVEGA WITH SPECIAL REFERENCE TO GENERALIZED ANXIETY DISORDER (GAD) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104047
Enrollment
70
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

None listed

Sponsors

Dr Tanvi Hundekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ICD-10GeneralisedAnxiety Disorder7 According to ICD10Diagnostic Criteria Patient are selected. (International Classification of Disease ) A period of at least six months with prominent tension, worry and feelings of apprehension ,about every day events and problems. Patients with the score in range between 13 to 24 on Hamilton Anxiety rating scale( mild) and (moderate) Age between 18 to 50 years

Exclusion criteria

Exclusion criteria: History of anxiety and worry for less than 6 months. Patient with suicidal tendency. Patients with the score in range above 18 on Hamelton Anxiety rating scale[Moderate and severe] Patient suffering from other psychiatric illness like mood disorder,epilepsyetc. Obsessive compulsive disorder. Having major systemic illness. Secondary GAD due to systemic conditions like uncontrolled DM, Hypertension,Hyperthyroidism, Cardiac disorders, deficiency status, neurological disorders and miscellaneous conditions. Socialphobia. Drugabuse.

Design outcomes

Primary

MeasureTime frame
Evaluate the effect of Mandukparni choorna in Chittodvega with special reference to Generalised Anxiety Disorder (GAD) on the basis of subjective and objective parameterafter1month of treatment duration.Timepoint: 0 , 15 , 30 th day 45th day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Tanvi Rajesh Hundekar

SMBT AYURVED COLLEGE AND HOSPITAL

hiramanwarungase@yahoo.com9420364157

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026